Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Both Moderna and Pfizer-BioNTech vaccines can produce antibodies that protect against ... but they're not immune to the virus ...

Getting an annual flu shot can be stressful for some people — especially those with autism, fragile X syndrome, ADHD and other neurodevelopmental disabilities. That’s where a specialized, seasonal ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Pfizer’s and Moderna's vaccine has been updated over time to ... for Davidson County Across the United States, KP.3.1.1 of the Omicron family, is the leading variant, accounting for 57% of ...

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

S eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season.

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

Yes, older Americans should get yet another COVID shot—but if you have already gotten the latest version, there's no rush.

On Monday, Merck & Co Inc (NYSE:MRK) and Moderna, Inc. (NASDAQ:MRNA) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational ...